Posts tagged PharmaTimes
First UK-based clinical trial focused viral vector manufacturer announces launch...
First UK-based clinical trial focused viral vector manufacturer announces launch...

ViroCell Biologics, the first clinical trial focused viral vector manufacturer in the UK, has announced its official launch, with the aim of becoming the ‘supplier of choice’ for viral vectors and gene modified cells.

Read More
In the NewsFlorence BuchananCDMO, clinical trials, viral vectors, cell and gene therapies, PharmaTimes, vector design, AAV vectors, lentivirus vectors, UK CDMO, CGT, gene therapy, cell therapy, Truell Conservation Foundation